Humaid Al-Shamsi, The Chairman of Nexomic, CEO of Burjeel Cancer Institute (BCI) Comprehensive Cancer Center, shared on LinkedIn:
“Heading, with God’s help, from Dubai to Doha to Berlin to lead the world’s largest contribution, with 10 specialized medical research papers on cancer, oncology, and artificial intelligence, at the European Cancer and Artificial Intelligence Association conference with the Nexomic team.
This contribution will include innovative methods we have developed to enhance the use of our intelligent platform for more accurate diagnosis and the selection of more precise and effective cancer treatments, especially in advanced cases.
These research papers are the result of more than a full year of dedicated work with our specialized team at Nexomic, which includes 25 PhD and postdoctoral researchers in this highly specialized field.
I am proud of our team and their outstanding efforts.
We ask God for success and guidance in finding effective solutions to this disease and for the opportunity to serve all of humanity.”
Other articles from Humaid Al-Shamsi on OncoDaily.